絞り込み

16404

広告

2317件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Use of direct oral anticoagulants in the first year after market entry of edoxaban: A Danish nationwide drug utilization study.

Non-valvular atrial fibrillation: impact of apixaban on patient outcomes.

Erratum: Quick reference guide to apixaban [Corrigendum].

[Medication adherence to non-vitamin K antagonist oral anticoagulants at non-valvular atrial fibrillation - the literature review].

Very Early Subclinical Valve Thrombosis After Transcatheter Aortic Valve Replacement.

Coagulation Testing in the Core Laboratory.

Direct oral anticoagulants use in elderly patients with non valvular atrial fibrillation: state of evidence.

Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial.

NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.

[Low or reduced? Semantics of the doses of new oral anticoagulants].

Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.

[Recent and upcoming randomized trials for left atrial appendage occlusion : Need for a definite assessment of the situation].

Meta-analysis of safety and efficacy for direct oral anticoagulation treatment of non-valvular atrial fibrillation in relation to renal function.

Correction to: Steven Deitelzweig et al., Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients.

Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin.

Initiation of direct oral anticoagulants versus warfarin for venous thromboembolism: impact on time to hospital discharge.

Real-world monitoring of direct oral anticoagulants in clinic and hospitalization settings.

Effect of Apixaban Versus Warfarin Use on Health Care Resource Utilization and Costs Among Elderly Patients with Nonvalvular Atrial Fibrillation.

Predicted risk of stroke and bleeding and use of oral anticoagulants in atrial fibrillation: Danish nationwide temporal trends 2011-2016.

A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります